Neha Garg

Title: Neha Garg: Innovator in Antimicrobial Research

Introduction

Neha Garg is a prominent inventor based in Urbana, IL (US). She has made significant contributions to the field of antimicrobial research, particularly through her innovative work on lantibiotics. Her research focuses on the development of novel antimicrobial compositions that have the potential to combat bacterial infections.

Latest Patents

Neha Garg holds a patent for "Class I and II lantibiotics from Geobacillus thermodenitrificans." This patent discloses the lantibiotics geobacillin I and geobacillin II, along with compositions that comprise these lantibiotics and methods for their use. The patent further details the sequences of geobacillin I and geobacillin II, as well as alternative structures that include amino acid substitutions. Additionally, it provides antimicrobial compositions that consist of one or more isolated geobacillins combined with a pharmaceutically acceptable carrier. The methods described in the patent aim to reduce bacterial reproduction by administering a therapeutically effective amount of the antimicrobial composition to a subject.

Career Highlights

Neha Garg is affiliated with the University of Illinois, where she conducts her research and contributes to the academic community. Her work has garnered attention for its potential applications in medicine and public health. With her innovative approach, she continues to advance the understanding of antimicrobial agents.

Collaborations

Neha has collaborated with notable researchers in her field, including Wilfred A Van Der Donk and Yuki Goto. These collaborations have enriched her research and expanded the impact of her work in antimicrobial science.

Conclusion

Neha Garg is a trailblazer in the field of antimicrobial research, with her patent on lantibiotics showcasing her innovative contributions. Her work at the University of Illinois and collaborations with esteemed colleagues further highlight her commitment to advancing science and improving public health.